Overexpression of ribosomal L22-like1 (RPL22L1) enhances cancer stem cell properties and promotes tumor progression in hepatocellular carcinoma (HCC)

被引：0
|
作者：
Huang, JinLin
Guo, Zhenyang
Luo, Jie
Liu, Beilei
Gong, Lanqi
Fang, Xiaona
Kwong, Dora Lai-Wan
Guan, Xinyuan
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-1489
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1489
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Ribosomal protein L22-like1 (RPL22L1) mediates sorafenib sensitivity via ERK in hepatocellular carcinoma
    Zhang, Dongmei
    Zhou, Yunzhen
    Ma, Yanan
    Jiang, Ping
    Lv, Hongchao
    Liu, Sijia
    Mu, Yu
    Zhou, Chong
    Xiao, Shan
    Ji, Guohua
    Liu, Peng
    Zhang, Ning
    Sun, Donglin
    Sun, Haiming
    Wu, Nan
    Jin, Yan
    CELL DEATH DISCOVERY, 2022, 8 (01)
  • [2] Ribosomal protein L22-like1 (RPL22L1) mediates sorafenib sensitivity via ERK in hepatocellular carcinoma
    Dongmei Zhang
    Yunzhen Zhou
    Yanan Ma
    Ping Jiang
    Hongchao Lv
    Sijia Liu
    Yu Mu
    Chong Zhou
    Shan Xiao
    Guohua Ji
    Peng Liu
    Ning Zhang
    Donglin Sun
    Haiming Sun
    Nan Wu
    Yan Jin
    Cell Death Discovery, 8
  • [3] Ribosomal L22-like1 (RPL22L1) Promotes Ovarian Cancer Metastasis by Inducing Epithelial-to-Mesenchymal Transition
    Wu, Nan
    Wei, Jia
    Wang, Yuhui
    Yan, Jinyan
    Qin, Ying
    Tong, Dandan
    Pang, Bo
    Sun, Donglin
    Sun, Haiming
    Yu, Yang
    Sun, Wenjing
    Meng, Xiangning
    Zhang, Chunyu
    Bai, Jing
    Chen, Feng
    Geng, Jingshu
    Lee, Ki-Young
    Fu, Songbin
    Jin, Yan
    PLOS ONE, 2015, 10 (11):
  • [4] The Ribosomal Protein Rpl22 Controls Ribosome Composition by Directly Repressing Expression of Its Own Paralog, Rpl22l1
    O'Leary, Monique N.
    Schreiber, Katherine H.
    Zhang, Yong
    Duc, Anne-Cecile E.
    Rao, Shuyun
    Hale, J. Scott
    Academia, Emmeline C.
    Shah, Shreya R.
    Morton, John F.
    Holstein, Carly A.
    Martin, Dan B.
    Kaeberlein, Matt
    Ladiges, Warren C.
    Fink, Pamela J.
    MacKay, Vivian L.
    Wiest, David L.
    Kennedy, Brian K.
    PLOS GENETICS, 2013, 9 (08):
  • [5] Ribosomal protein L22-like1 promotes prostate cancer progression by activating PI3K/Akt/mTOR signalling pathway
    Yi, Xiaoyu
    Zhang, Chao
    Liu, Baojie
    Gao, Guojun
    Tang, Yaqi
    Lu, Yongzheng
    Pan, Zhifang
    Wang, Guohui
    Feng, Weiguo
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2023, 27 (03) : 403 - 411
  • [6] RPL22L1, a novel candidate oncogene promotes temozolomide resistance by activating STAT3 in glioblastoma
    Chen, Yunping
    Mu, Yu
    Guan, Qing
    Li, Chenlong
    Zhang, Yangong
    Xu, Yinzhi
    Zhou, Chong
    Guo, Ying
    Ma, Yanan
    Zhao, Meiqi
    Ji, Guohua
    Liu, Peng
    Sun, Donglin
    Sun, Haiming
    Wu, Nan
    Jin, Yan
    CELL DEATH & DISEASE, 2023, 14 (11)
  • [7] RPL22L1, a novel candidate oncogene promotes temozolomide resistance by activating STAT3 in glioblastoma
    Yunping Chen
    Yu Mu
    Qing Guan
    Chenlong Li
    Yangong Zhang
    Yinzhi Xu
    Chong Zhou
    Ying Guo
    Yanan Ma
    Meiqi Zhao
    Guohua Ji
    Peng Liu
    Donglin Sun
    Haiming Sun
    Nan Wu
    Yan Jin
    Cell Death & Disease, 14
  • [8] RPL22L1 induction in colorectal cancer is associated with poor prognosis and 5-FU resistance
    Rao, Shuyun
    Peri, Suraj
    Hoffmann, Jens
    Cai, Kathy Q.
    Harris, Bryan
    Rhodes, Michele
    Connolly, Denise C.
    Testa, Joseph R.
    Wiest, David L.
    PLOS ONE, 2019, 14 (10):
  • [9] Knockdown of ribosomal protein L22-like 1 arrests the cell cycle and promotes apoptosis in colorectal cancer
    Li, Chunming
    Du, Xinna
    Zhang, Hu
    Liu, Shuang
    CYTOJOURNAL, 2024, 21
  • [10] Identification of candidate diagnostic and prognostic biomarkers for human prostate cancer: RPL22L1 and RPS21
    Liang, Zumu
    Mou, Qingjie
    Pan, Zhiwei
    Zhang, Qiang
    Gao, Guojun
    Cao, Yingying
    Gao, Zhiqin
    Pan, Zhifang
    Feng, Weiguo
    MEDICAL ONCOLOGY, 2019, 36 (06)
12345